De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit
Open Access
- 17 December 2010
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 14 (6) , R225
Abstract
Introduction: Most data on de-escalation of empirical antimicrobial therapy has focused on ventilator-associated pneumonia. In this retrospective monocentric study, we evaluated de-escalation as part of a global strategy of empiric antibiotherapy management irrespective of the location and the severity of the infection. The goal of this trial was to assess the application of a de-escalation strategy and the impact in terms of re-escalation, recurrent infection and to identify variables associated with de-escalation. Methods: All consecutive patients treated with empiric antibiotic therapy and hospitalized in the intensive care unit for at least 72 hours within a period of 16 months were included. We compared the characteristics and outcome of patients who have experienced de-escalation therapy with those who have not. Results: A total of 116 patients were studied corresponding to 133 infections. Antibiotic therapy was de-escalated in 60 cases (45%). De-escalation, primarily accomplished by a reduction in the number of antibiotics used, was observed in 52% of severe sepsis or septic shock patients. Adequate empiric antibiotic and use of aminoglycoside were independently linked with de-escalation. De-escalation therapy was associated with a significant reduction of recurrent infection (19% vs 5% P = 0.01). Mortality was not changed by de-escalation. Conclusions: As part of a global management of empiric antibiotherapy in an intensive care unit, de-escalation might be safe and feasible in a large proportion of patients.Keywords
This publication has 27 references indexed in Scilit:
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Critical Care Medicine, 2008
- Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse*Critical Care Medicine, 2007
- De-escalation therapy in ventilator-associated pneumoniaCurrent Opinion in Critical Care, 2006
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Strategies to prevent antimicrobial resistance in the intensive care unitCritical Care Medicine, 2005
- Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Improved survival of critically ill cancer patients with septic shockIntensive Care Medicine, 2003
- Current Epidemiology of Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Inadequate Antimicrobial Treatment of InfectionsChest, 1999
- Incidence, Risk, and Prognosis Factors of Nosocomial Pneumonia in Mechanically Ventilated PatientsAmerican Review of Respiratory Disease, 1990